GMP-Based Isolation of Full-Term Human Placenta-Derived NK Cells for CAR-NK Cell Therapy in Malignant Melanoma

https://ctrmrc.tums.ac.ir/news/GMP–Based-Isolation-of-Full–Term-Human-Placenta–Derived-NK-Cells-for-CAR–NK-Cell-Therapy-in-Malignant-Melanoma

placenta, which offers benefits compared to other sources due to their limited ex vivo expansion potential. Recent studies have indicated the capacity to expand functional NK cells from placenta-derived cells in vitro that possess anti-tumor cytolytic...